Ironwood Investment Management’s Checkpoint Therapeutics CKPT Stock Holding History
Bought
Maintained
Sold
Other funds holding CKPT
BCM
HCM
GCL
OBAM
GF
GCIA
GLF
Ironwood Investment Management's CKPT Position: Q1 2025 in Review
Ironwood Investment Management sold out of Checkpoint Therapeutics (CKPT) in Q1 2025, closing a stake of 12,566 shares — an estimated $40.2K sold.
Ironwood Investment Management first reported a position in CKPT in Q3 2020 and held it in 18 quarters. The position peaked at $435K in Q3 2021. 84 funds tracked by Wall St. Rank hold CKPT as of Q1 2025.
- Ironwood Investment Management reported no remaining Checkpoint Therapeutics position as of Q1 2025 after selling out during the quarter.
- Ironwood Investment Management sold 12,566 Checkpoint Therapeutics shares in Q1 2025, an estimated $40.2K.
- Ironwood Investment Management first reported a position in Checkpoint Therapeutics in Q3 2020 and held it in 18 quarters.
- Ironwood Investment Management's Checkpoint Therapeutics position peaked at $435K in Q3 2021.
- 84 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q1 2025.
Based on Ironwood Investment Management's 13F filing for Q1 2025, filed 15 May 2025.